AGREEMENT AND PLAN OF MERGER BY AND AMONG CORTEX PHARMACEUTICALS, INC., PIER ACQUISITION CORP. AND PIER PHARMACEUTICALS, INC. AUGUST 10, 2012Merger Agreement • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 14th, 2020 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of August 10, 2012 (the “Agreement Date”) by and among Cortex Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Pier Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”), and Pier Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG CORTEX PHARMACEUTICALS, INC., PIER ACQUISITION CORP. AND PIER PHARMACEUTICALS, INC. AUGUST 10, 2012Merger Agreement • August 16th, 2012 • Cortex Pharmaceuticals Inc/De/ • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 16th, 2012 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of August 10, 2012 (the “Agreement Date”) by and among Cortex Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Pier Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”), and Pier Pharmaceuticals, Inc., a Delaware corporation (the “Company”).